Friess Associates’s GSK GSK Stock Holding History

Friess Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,504	Closed	-$100K	–	159
2013 Q4	$100K	Buy	1,504 +64	+4%	+$4.15K	0.01%	130
2013 Q3	$90K	Sell	1,440 -142,000	-99%	-$9.14M	0.01%	127
2013 Q2	$8.96M	Buy	+143,440	New	+$9.1M	0.7%	55

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Friess Associates's GSK Position: Q1 2014 in Review

Friess Associates sold out of GSK (GSK) in Q1 2014, closing a stake of 1,504 shares — an estimated $100K sold.

Friess Associates first reported a position in GSK in Q2 2013 and held it in 3 quarters. The position peaked at $8.96M in Q2 2013. 712 funds tracked by Wall St. Rank hold GSK as of Q1 2014.

Friess Associates reported no remaining GSK position as of Q1 2014 after selling out during the quarter.
Friess Associates sold 1,504 GSK shares in Q1 2014, an estimated $100K.
Friess Associates first reported a position in GSK in Q2 2013 and held it in 3 quarters.
Friess Associates's GSK position peaked at $8.96M in Q2 2013.
712 funds tracked by Wall St. Rank held GSK as of Q1 2014.

Based on Friess Associates's 13F filing for Q1 2014, filed 15 May 2014.